| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgment of uncertainty: A fundamental means to ensure scientific and ethical validity in clinical research
|
Djulbegovic, Benjamin
|
|
2001
|
|
5 |
p. 389-395
|
artikel
|
| 2 |
Adaptive randomization in a treatment study of patients with adverse karyotype acute myeloid leukemia
|
Estey, Elihu H.
|
|
2003
|
|
5 |
p. 390
|
artikel
|
| 3 |
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer
|
Natale, Ronald B.
|
|
2000
|
|
5 |
p. 386-393
|
artikel
|
| 4 |
Adjuvant Chemo-/Hormonal Therapy Trials for Locally Advanced Prostate Cancer
|
Vaishampayan, Ulka
|
|
2000
|
|
5 |
p. 402-408
|
artikel
|
| 5 |
Advances in the molecular genetics of acute leukemia
|
Scandura, Joseph M.
|
|
2005
|
|
5 |
p. 323-332
|
artikel
|
| 6 |
Advances in the treatment of chronic lymphocytic leukemia
|
Lamanna, Nicole
|
|
2005
|
|
5 |
p. 333-338
|
artikel
|
| 7 |
Advances in the understanding of biology and prognosis in chronic lymphocytic leukemia
|
Zent, Clive S.
|
|
2004
|
|
5 |
p. 348-354
|
artikel
|
| 8 |
Allogeneic stem-cell transplantation in renal-cell carcinoma
|
Hayes-Lattin, Brandon M.
|
|
2001
|
|
5 |
p. 433-437
|
artikel
|
| 9 |
Application of advances in molecular biology to the treatment of brain tumors
|
Takeshima, Hideo
|
|
2000
|
|
5 |
p. 425-433
|
artikel
|
| 10 |
Assessing the quality of clinical trials: Can it be done?
|
Bennett, Charles L.
|
|
2001
|
|
5 |
p. 387-388
|
artikel
|
| 11 |
Changing role and decreasing size: Current trends in radiotherapy for hodgkin’s disease
|
Yahalom, Joachim
|
|
2002
|
|
5 |
p. 415-423
|
artikel
|
| 12 |
Characterization of tumor specimens for a targeted therapy in metastatic renal cell carcinoma patients
|
Raspollini, Maria Rosaria
|
|
2007
|
|
5 |
p. 331
|
artikel
|
| 13 |
Chemoprevention of melanoma
|
Demierre, Marie-France
|
|
2004
|
|
5 |
p. 406-413
|
artikel
|
| 14 |
Chemotherapy for androgenindependent prostate cancer: Myth or reality
|
Kelly, Wm. Kevin
|
|
2000
|
|
5 |
p. 394-401
|
artikel
|
| 15 |
Chronic lymphocytic leukemia: Biology and current treatment
|
Zent, Clive S.
|
|
2007
|
|
5 |
p. 345-352
|
artikel
|
| 16 |
Clinical and molecular prognostic factors in follicular lymphoma
|
Davies, Andrew J.
|
|
2006
|
|
5 |
p. 358-367
|
artikel
|
| 17 |
Clinical Trials Report
|
Portlock, Carol S.
|
|
2002
|
|
5 |
p. 413-414
|
artikel
|
| 18 |
Clinical Trials Report
|
Margolin, Kim
|
|
2004
|
|
5 |
p. 399-400
|
artikel
|
| 19 |
Clinical Trials Report
|
Portlock, Carol S.
|
|
2004
|
|
5 |
p. 357-359
|
artikel
|
| 20 |
Clinical Trials Report
|
Margolin, Kim
|
|
2005
|
|
5 |
p. 375-376
|
artikel
|
| 21 |
Combination therapy in hormone-refractory prostate cancer
|
Petrylak, Daniel P.
|
|
2001
|
|
5 |
p. 453
|
artikel
|
| 22 |
Comparison of ABVD chemotherapy and a regimen including radiotherapy in patients with limited-stage Non-Hodgkin’s lymphoma
|
Portlock, Carol S.
|
|
2006
|
|
5 |
p. 355-356
|
artikel
|
| 23 |
Complementary and alternative medicine in prostate cancer
|
Jacobson, Judith S.
|
|
2001
|
|
5 |
p. 448-452
|
artikel
|
| 24 |
Conflict of interest in industrysponsored economic evaluations: Real or imagined?
|
Barbieri, Marco
|
|
2001
|
|
5 |
p. 410-413
|
artikel
|
| 25 |
Cytogenetics in acute myeloid leukemia
|
Schoch, Claudia
|
|
2002
|
|
5 |
p. 390-397
|
artikel
|
| 26 |
Cytotoxic chemotherapy: Advances in delivery, pharmacology, and testing
|
Ciordia, Roberto
|
|
2000
|
|
5 |
p. 445-453
|
artikel
|
| 27 |
Detection of minimal residual disease in acute myeloid leukemia
|
Baer, Maria R.
|
|
2002
|
|
5 |
p. 398-402
|
artikel
|
| 28 |
Diagnosis and treatment of acute promyelocytic leukemia
|
Jurcic, Joseph G.
|
|
2007
|
|
5 |
p. 337-344
|
artikel
|
| 29 |
Diffuse large B-cell lymphomas with plasmablastic differentiation
|
Teruya-Feldstein, Julie
|
|
2005
|
|
5 |
p. 357-363
|
artikel
|
| 30 |
Distinct sets of genetic alterations in melanoma
|
Margolin, Kim
|
|
2006
|
|
5 |
p. 398-399
|
artikel
|
| 31 |
Does palliative chemotherapy palliate?
|
Markman, Maurie
|
|
2002
|
|
5 |
p. 361
|
artikel
|
| 32 |
Early blast clearance by remission induction as a prognostic factor in acute myeloid leukemia
|
Estey, Elihu H.
|
|
2003
|
|
5 |
p. 389
|
artikel
|
| 33 |
Economic analysis of randomized, controlled trials
|
Lyman, Gary H.
|
|
2001
|
|
5 |
p. 396-403
|
artikel
|
| 34 |
Enzastaurin, a Targeted PKCβ Inhibitor, in Relapsed or Refractory DLBCL: A Promising New Strategy Based on Gene Expression Signature
|
Portlock, Carol S.
|
|
2007
|
|
5 |
p. 371-372
|
artikel
|
| 35 |
FDG-PET after two cycles of chemotherapy predicts treatment failure and Progression-free survival in Hodgkin’s lymphoma
|
Portlock, Carol S.
|
|
2006
|
|
5 |
p. 356-357
|
artikel
|
| 36 |
Fertility preservation and management of gonadal failure associated with lymphoma therapy
|
Howell, Simon J.
|
|
2002
|
|
5 |
p. 443-452
|
artikel
|
| 37 |
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
|
Stadtmauer, Edward A.
|
|
2002
|
|
5 |
p. 375-380
|
artikel
|
| 38 |
Gene therapy for brain tumors
|
Bansal, Kanti
|
|
2000
|
|
5 |
p. 463-472
|
artikel
|
| 39 |
Gene therapy for prostate cancer
|
Gingrich, Jeffrey R.
|
|
2001
|
|
5 |
p. 438-447
|
artikel
|
| 40 |
Hairy cell leukemia
|
Dearden, Claire
|
|
2006
|
|
5 |
p. 337-342
|
artikel
|
| 41 |
Immunologic monitoring in adults with acute lymphoblastic leukemia
|
Vidriales, María-Belén
|
|
2003
|
|
5 |
p. 413-418
|
artikel
|
| 42 |
Immunologic monitoring in chronic lymphocytic leukemia
|
Wierda, William G.
|
|
2003
|
|
5 |
p. 419-425
|
artikel
|
| 43 |
Immunotherapy for acute myeloid leukemia
|
Jurcic, Joseph G.
|
|
2005
|
|
5 |
p. 339-346
|
artikel
|
| 44 |
Immunotherapy for melanoma: The good, the bad, and the future
|
Poehlein, Christian H.
|
|
2005
|
|
5 |
p. 383-392
|
artikel
|
| 45 |
Immunotherapy for prostate cancer
|
Rini, Brian I.
|
|
2001
|
|
5 |
p. 418-423
|
artikel
|
| 46 |
Intermittent androgen deprivation
|
Dawson, Nancy A.
|
|
2000
|
|
5 |
p. 409-416
|
artikel
|
| 47 |
Investigational strategies in autologous stem cell transplantation for follicular lymphoma
|
Weigert, Oliver
|
|
2006
|
|
5 |
p. 368-375
|
artikel
|
| 48 |
Is cancer care best at high-volume providers?
|
Hillner, Bruce E.
|
|
2001
|
|
5 |
p. 404-409
|
artikel
|
| 49 |
Is it good clinical judgment or selection bias?
|
Markman, Maurie
|
|
2001
|
|
5 |
p. 377-378
|
artikel
|
| 50 |
Linking KSHV to human cancer
|
Wong, Emily L.
|
|
2005
|
|
5 |
p. 349-356
|
artikel
|
| 51 |
Literatuer alert
|
|
|
2002
|
|
5 |
p. 364-366
|
artikel
|
| 52 |
Literature alert
|
|
|
2000
|
|
5 |
p. 373-375
|
artikel
|
| 53 |
Literature alert
|
|
|
2004
|
|
5 |
p. 333-335
|
artikel
|
| 54 |
Literature alert
|
|
|
2001
|
|
5 |
p. 381-383
|
artikel
|
| 55 |
Literature alert
|
|
|
2003
|
|
5 |
p. 351-353
|
artikel
|
| 56 |
Lymphocyte predominant Hodgkin’s disease
|
Ekstrand, Bradley C.
|
|
2002
|
|
5 |
p. 424-433
|
artikel
|
| 57 |
Management of acute promyelocytic leukemia
|
Tallman, Martin S.
|
|
2002
|
|
5 |
p. 381-389
|
artikel
|
| 58 |
Management of metastatic melanoma patients with brain metastases
|
Majer, Martin
|
|
2007
|
|
5 |
p. 411-416
|
artikel
|
| 59 |
Mantle cell lymphoma: Evolving novel options
|
Goy, Andre
|
|
2007
|
|
5 |
p. 391-398
|
artikel
|
| 60 |
Melanoma genomics
|
Kashani-Sabet, Mohammed
|
|
2004
|
|
5 |
p. 401-405
|
artikel
|
| 61 |
Minimal residual disease quantification in adult acute lymphoblastic leukemia
|
Landau, Heather
|
|
2006
|
|
5 |
p. 323-324
|
artikel
|
| 62 |
Molecular diagnosis in lymphoma
|
Bagg, Adam
|
|
2004
|
|
5 |
p. 369-379
|
artikel
|
| 63 |
Monitoring AML1-ETO and CBFΒ-MYH11 transcripts in acute myeloid leukemia
|
Liu Yin, John A.
|
|
2003
|
|
5 |
p. 399-404
|
artikel
|
| 64 |
Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemia
|
Oehler, Vivian G.
|
|
2003
|
|
5 |
p. 426-435
|
artikel
|
| 65 |
Monitoring of acute myeloid leukemia by flow cytometry
|
Kern, Wolfgang
|
|
2003
|
|
5 |
p. 405-412
|
artikel
|
| 66 |
Monitoring PML-RARα in acute promyelocytic leukemia
|
Jurcic, Joseph G.
|
|
2003
|
|
5 |
p. 391-398
|
artikel
|
| 67 |
Multi-agent cytostatic treatment of ‘low-grade’ gliomas
|
Linskey, Mark E.
|
|
2000
|
|
5 |
p. 454-462
|
artikel
|
| 68 |
Multidisciplinary management of special melanoma situations: Oligometastatic disease and bulky nodal sites
|
Sarnaik, Amod A.
|
|
2007
|
|
5 |
p. 417-427
|
artikel
|
| 69 |
Mycosis fungoides and sezary syndrome: An update
|
Kim, Ellen J.
|
|
2006
|
|
5 |
p. 376-386
|
artikel
|
| 70 |
Neurosurgical advances in the treatment of brain tumors
|
Olson, Jeffrey J.
|
|
2000
|
|
5 |
p. 434-437
|
artikel
|
| 71 |
New approaches to treatment of metastatic bladder cancer
|
Edelman, Martin J.
|
|
2000
|
|
5 |
p. 379-385
|
artikel
|
| 72 |
New developments in autologous tumor cell vaccination therapy for renal cell carcinoma
|
Eertwegh, Alfons JM van den
|
|
2000
|
|
5 |
p. 369-371
|
artikel
|
| 73 |
New developments in immunotherapy for non-Hodgkin’s lymphoma
|
Leonard, John P.
|
|
2005
|
|
5 |
p. 364-371
|
artikel
|
| 74 |
New drugs in acute myeloid leukemia
|
Giles, Francis J.
|
|
2002
|
|
5 |
p. 369-374
|
artikel
|
| 75 |
New molecular targets for treatment of lymphoma
|
Pro, Barbara
|
|
2004
|
|
5 |
p. 360-368
|
artikel
|
| 76 |
New strategies in radioimmunotherapy for lymphoma
|
Pandit-Taskar, Neeta
|
|
2003
|
|
5 |
p. 364-371
|
artikel
|
| 77 |
New treatment approaches for metastatic renal cell carcinoma
|
Nanus, David M.
|
|
2000
|
|
5 |
p. 417-422
|
artikel
|
| 78 |
New treatments for chronic lymphocytic leukemia
|
Chanan-Khan, Asher A.
|
|
2007
|
|
5 |
p. 353-360
|
artikel
|
| 79 |
Non-Hodgkin’s lymphoma in children and adolescents
|
Shukla, Neerav N.
|
|
2006
|
|
5 |
p. 387-394
|
artikel
|
| 80 |
Novel approaches in allogeneic stem cell transplantation
|
Papadopoulos, Esperanza B.
|
|
2006
|
|
5 |
p. 325-336
|
artikel
|
| 81 |
Novel approaches to immunotherapy for B-cell malignancies
|
Brentjens, Renier J.
|
|
2004
|
|
5 |
p. 339-347
|
artikel
|
| 82 |
Older adults with acute myeloid leukemia
|
Sekeres, Mikkael A.
|
|
2002
|
|
5 |
p. 403-409
|
artikel
|
| 83 |
Overview of melanoma vaccines and promising approaches
|
Panelli, Monica C.
|
|
2004
|
|
5 |
p. 414-420
|
artikel
|
| 84 |
Pentostatin, cyclophosphamide, and rituximab show significant clinical activity in patients with previously untreated chronic lymphocytic leukemia
|
Lamanna, Nicole
|
|
2007
|
|
5 |
p. 335-336
|
artikel
|
| 85 |
Philadelphia chromosome-positive acute lymphoblastic leukemia: Impact of imatinib treatment on remission induction and allogeneic stem cell transplantation
|
Kovacsovics, Tibor
|
|
2006
|
|
5 |
p. 343-351
|
artikel
|
| 86 |
Posttransplant lymphoproliferative disease: Pathogenesis, monitoring, and therapy
|
Ambinder, Richard F.
|
|
2003
|
|
5 |
p. 359-363
|
artikel
|
| 87 |
Primary central nervous system lymphoma
|
Gavrilovic, Igor T.
|
|
2004
|
|
5 |
p. 388-395
|
artikel
|
| 88 |
Radiotherapy for brain tumors
|
Mehta, Minesh P.
|
|
2000
|
|
5 |
p. 438-444
|
artikel
|
| 89 |
Randomized trials in oncology: A fertile ground for controversy
|
Markman, Maurie
|
|
2003
|
|
5 |
p. 347-348
|
artikel
|
| 90 |
Recognizing the toxicity of “Nontoxic” drugs employed in the management of malignant disease
|
Markman, Maurie
|
|
2007
|
|
5 |
p. 329-330
|
artikel
|
| 91 |
Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma
|
Portlock, Carol S.
|
|
2003
|
|
5 |
p. 357
|
artikel
|
| 92 |
Rituximab for lymphocyte-predominant Hodgkin’s disease
|
Portlock, Carol S.
|
|
2003
|
|
5 |
p. 358
|
artikel
|
| 93 |
Rituximab maintenance in indolent lymphoma: Indications and controversies
|
Oers, Marinus H.J. van
|
|
2007
|
|
5 |
p. 378-383
|
artikel
|
| 94 |
Sentinel node biopsy or nodal observation
|
Margolin, Kim
|
|
2007
|
|
5 |
p. 401-402
|
artikel
|
| 95 |
Simian virus 40 and its association with human lymphomas
|
Vilchez, Regis A.
|
|
2003
|
|
5 |
p. 372-379
|
artikel
|
| 96 |
Sun exposure and mortality from melanoma
|
Margolin, Kim
|
|
2006
|
|
5 |
p. 397
|
artikel
|
| 97 |
The genetics of familial lymphomas
|
Siddiqui, Rina
|
|
2004
|
|
5 |
p. 380-387
|
artikel
|
| 98 |
The “new” era of oral antineoplastic drug therapy: Revisiting “old” concerns
|
Markman, Maurie
|
|
2006
|
|
5 |
p. 317-318
|
artikel
|
| 99 |
The patient and web-based cancer information: A role for provider input into this rapidly evolving relationship
|
Markman, Timothy M.
|
|
2005
|
|
5 |
p. 313-314
|
artikel
|
| 100 |
Therapeutic targets in melanoma: MAPKinase pathway
|
Haluska, Frank G.
|
|
2006
|
|
5 |
p. 400-405
|
artikel
|
| 101 |
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome
|
Borthakur, Gautam
|
|
2007
|
|
5 |
p. 373-377
|
artikel
|
| 102 |
The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance
|
Sampath, Deepa
|
|
2007
|
|
5 |
p. 361-367
|
artikel
|
| 103 |
The role of resection for patients with renal carcinoma
|
Flanigan, Robert C.
|
|
2001
|
|
5 |
p. 424-432
|
artikel
|
| 104 |
Tumor cell and circulating markers in melanoma: Diagnosis, prognosis, and management
|
Kounalakis, Nicole
|
|
2005
|
|
5 |
p. 377-382
|
artikel
|
| 105 |
Unusual histologic and clinical variants of melanoma: Implications for therapy
|
Crowson, A. Neil
|
|
2007
|
|
5 |
p. 403-410
|
artikel
|
| 106 |
Update on HIV lymphoma
|
Noy, Ariela
|
|
2007
|
|
5 |
p. 384-390
|
artikel
|
| 107 |
Vaccination strategies for lymphomas
|
Dar, Mohammed M.
|
|
2003
|
|
5 |
p. 380-386
|
artikel
|
| 108 |
Web alert
|
|
|
2002
|
|
5 |
p. 362-363
|
artikel
|
| 109 |
Web alert
|
|
|
2000
|
|
5 |
p. 376
|
artikel
|
| 110 |
Web alert
|
|
|
2001
|
|
5 |
p. 379-380
|
artikel
|
| 111 |
Web alert
|
|
|
2005
|
|
5 |
p. 315-319
|
artikel
|
| 112 |
Web Alert
|
|
|
2007
|
|
5 |
p. 332
|
artikel
|
| 113 |
Web alert
|
|
|
2004
|
|
5 |
p. 331-332
|
artikel
|
| 114 |
Web alert
|
|
|
2006
|
|
5 |
p. 319
|
artikel
|
| 115 |
Web alert
|
|
|
2003
|
|
5 |
p. 349-350
|
artikel
|
| 116 |
What is the clinically relevant endpoint for cancer prevention trials?
|
Markman, Maurie
|
|
2004
|
|
5 |
p. 329-330
|
artikel
|
| 117 |
ziPeripheral T-cell lymphoma
|
Au, Wing Y.
|
|
2002
|
|
5 |
p. 434-442
|
artikel
|
Tijdschrift beschrijving